HempLife Today to begin Trial Offer of its popular CannazALL CBD GelCaps as completed BETA testing indicates this offer will add 25,000 to 50,000 new customers in the next 12 to14 months

DENVER, CO UBQU, (Marketwired Nov 1, 2016) CEO of Ubiquitech Software Corp. (OTC PINK: UBQU), with pending symbol and name change to HempLife Today™, and the management of HempLife Today™ are announcing that it has completed a very successful BETA test of the previously announced (9.16.2016) Trial Offer of its popular CannazALL™ CBD GelCaps and will now start this campaign to the general public. This Trial Offer will differ slightly from the originally announced offer and cost just $9.95
http://bit.ly/2fAUS5F